CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1
Clinical trial NCT01773707 · COMPLETED
Trial details
- NCT number
- NCT01773707
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-01
- Primary completion
- 2021-12-14
- Enrollment
- 212
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.